Saudi Healthcare Providers’ Perspectives and Clinical Practice of Anti-Obesity Medications: A National Survey
Background: The rising prevalence of obesity is associated with significant health risks, underscoring the need for effective prevention and treatment. The use of anti-obesity medications (AOMs) remains limited due to several barriers. Objectives: To physicians’ perspectives and clinical practices r...
Saved in:
| Main Authors: | Haifa F. AlOtaibi, Sahar Alnasrallah, Assim A. Alfadda, Samar A. Alquassayer, Amr A. Arafat, Shadan AlMuhaidib, Rawabi M. Alsayer, Saleh A. Alqahtani, Waleed Alhazzani |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2025-07-01
|
| Series: | Saudi Journal of Medicine and Medical Sciences |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/sjmms.sjmms_672_24 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
GLP-1 Agonists, Willpower, and Weight Stigma: A Paradigm Shift for Obesity
by: Pablo Arrona-Cardoza
Published: (2025-08-01) -
GLP-1 receptor agonists in IBD: exploring the crossroads of metabolism and inflammation
by: Giulia Migliorisi, et al.
Published: (2025-07-01) -
Barriers to glucagon-like peptide-1 agonists used for obesity management among the general population in Tabuk City, Saudi Arabia, and their relation to smoking cessation and antidepressants
by: Amirah Alhowiti, et al.
Published: (2025-07-01) -
The Potential Role of Glucagon-Like Peptide-1 Receptor Agonists in Polycystic Ovary Syndrome: A Narrative Review
by: Kamil Turlej, et al.
Published: (2025-07-01) -
The effect of beinaglutide as an glucagon-like peptide-1 receptor agonists on cardiometabolic factors: a systematic review and meta-analysis
by: Yan Xu, et al.
Published: (2025-04-01)